TY - JOUR
T1 - CABANA trial
T2 - “beauty is in the eye of the beholder”
AU - Briceno, David
AU - Mohanty, Prasant
AU - Di Biase, Luigi
AU - Romero, Jorge
AU - Rocca, Domenico Giovanni Della
AU - Trivedi, Chintan
AU - Mohanty, Sanghamitra
AU - Natale, Andrea
PY - 2020/1/1
Y1 - 2020/1/1
N2 - The CABANA trial reported that catheter ablation, when compared with drug therapy, did not significantly reduce the primary composite end point of death, disabling stroke, serious bleeding, or cardiac arrest in patients with atrial fibrillation. Despite multiple limitations in study design, the CABANA trial still confirmed that catheter ablation of atrial fibrillation led to clinically important and significant improvements in quality of life at 12 months without increasing the risk of complications.
AB - The CABANA trial reported that catheter ablation, when compared with drug therapy, did not significantly reduce the primary composite end point of death, disabling stroke, serious bleeding, or cardiac arrest in patients with atrial fibrillation. Despite multiple limitations in study design, the CABANA trial still confirmed that catheter ablation of atrial fibrillation led to clinically important and significant improvements in quality of life at 12 months without increasing the risk of complications.
KW - Ablation
KW - Atrila fibrillation
KW - Mortality
KW - Outcomes
UR - http://www.scopus.com/inward/record.url?scp=85071752613&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071752613&partnerID=8YFLogxK
U2 - 10.1007/s10840-019-00604-0
DO - 10.1007/s10840-019-00604-0
M3 - Comment/debate
C2 - 31493123
AN - SCOPUS:85071752613
VL - 57
JO - Journal of Interventional Cardiac Electrophysiology
JF - Journal of Interventional Cardiac Electrophysiology
SN - 1383-875X
IS - 1
ER -